Design of simultaneous antimicrobial and anticoagulant surfaces based on nanoparticles and polysaccharides†

Doris Breitwieser; Stefan Spirk; Hubert Fasl; Heike M.A. Ehmann; Angela Chemelli; Victoria Reichel; Christian Gspan; Karin Stana-Kleinschek; Volker Ribitsch

doi:10.1039/c3tb00272a

Design of simultaneous antimicrobial and anticoagulant surfaces based on nanoparticles and polysaccharides†

Doris Breitwieser, Stefan Spirk^*, Hubert Fasl, Heike M.A. Ehmann, Angela Chemelli, Victoria Reichel, Christian Gspan, Karin Stana-Kleinschek, Volker Ribitsch

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

Abstract

The rational design of silver nanoparticles encapsulated in an anticoagulant, hemocompatible polysaccharide, 6-O-chitosan sulfate, is presented. Three different approaches are described for the immobilization of these core shell particles on cellulosic surfaces. The mass of the immobilized particles is quantified using a quartz crystal microbalance with dissipation (QCM-D). The antimicrobial activity of the surfaces towards E. coli MG 1655 [R1-16] is investigated by live/dead assays using fluorescence staining. All surfaces treated with the designed nanoparticles exhibit excellent antimicrobial activity towards E. coli MG 1655 [R1-16]. Anticoagulant properties of blood plasma on the nanoparticle treated surfaces have been determined using QCM-D. In comparison with the unmodified substrates, the total coagulation time as well as the thrombin formation time and fibrin clotting time of surfaces modified with nanoparticles are significantly increased.

Original language	English
Pages (from-to)	2022-2030
Number of pages	9
Journal	Journal of Materials Chemistry B
Volume	1
Issue number	15
DOIs	https://doi.org/10.1039/c3tb00272a https://doi.org/10.1039/C3TB00272A
Publication status	Published - 2013

Fields of Expertise

Advanced Materials Science

Treatment code (Nähere Zuordnung)

Basic - Fundamental (Grundlagenforschung)
Application
Experimental

Access to Document

Cite this

Breitwieser, D., Spirk, S., Fasl, H., Ehmann, H. M. A., Chemelli, A., Reichel, V., Gspan, C., Stana-Kleinschek, K., & Ribitsch, V. (2013). Design of simultaneous antimicrobial and anticoagulant surfaces based on nanoparticles and polysaccharides†. Journal of Materials Chemistry B, 1(15), 2022-2030. https://doi.org/10.1039/c3tb00272a, https://doi.org/10.1039/C3TB00272A

Breitwieser, D, Spirk, S, Fasl, H, Ehmann, HMA, Chemelli, A, Reichel, V, Gspan, C, Stana-Kleinschek, K & Ribitsch, V 2013, 'Design of simultaneous antimicrobial and anticoagulant surfaces based on nanoparticles and polysaccharides†', Journal of Materials Chemistry B, vol. 1, no. 15, pp. 2022-2030. https://doi.org/10.1039/c3tb00272a, https://doi.org/10.1039/C3TB00272A

@article{ca6aced119f8454b902a2b6aa70fde65,

title = "Design of simultaneous antimicrobial and anticoagulant surfaces based on nanoparticles and polysaccharides†",

abstract = "The rational design of silver nanoparticles encapsulated in an anticoagulant, hemocompatible polysaccharide, 6-O-chitosan sulfate, is presented. Three different approaches are described for the immobilization of these core shell particles on cellulosic surfaces. The mass of the immobilized particles is quantified using a quartz crystal microbalance with dissipation (QCM-D). The antimicrobial activity of the surfaces towards E. coli MG 1655 [R1-16] is investigated by live/dead assays using fluorescence staining. All surfaces treated with the designed nanoparticles exhibit excellent antimicrobial activity towards E. coli MG 1655 [R1-16]. Anticoagulant properties of blood plasma on the nanoparticle treated surfaces have been determined using QCM-D. In comparison with the unmodified substrates, the total coagulation time as well as the thrombin formation time and fibrin clotting time of surfaces modified with nanoparticles are significantly increased.",

author = "Doris Breitwieser and Stefan Spirk and Hubert Fasl and Ehmann, {Heike M.A.} and Angela Chemelli and Victoria Reichel and Christian Gspan and Karin Stana-Kleinschek and Volker Ribitsch",

year = "2013",

doi = "10.1039/c3tb00272a",

language = "English",

volume = "1",

pages = "2022--2030",

journal = "Journal of Materials Chemistry B",

issn = "2050-7518",

publisher = "Royal Society of Chemistry",

number = "15",

}

TY - JOUR

T1 - Design of simultaneous antimicrobial and anticoagulant surfaces based on nanoparticles and polysaccharides†

AU - Breitwieser, Doris

AU - Spirk, Stefan

AU - Fasl, Hubert

AU - Ehmann, Heike M.A.

AU - Chemelli, Angela

AU - Reichel, Victoria

AU - Gspan, Christian

AU - Stana-Kleinschek, Karin

AU - Ribitsch, Volker

PY - 2013

Y1 - 2013

N2 - The rational design of silver nanoparticles encapsulated in an anticoagulant, hemocompatible polysaccharide, 6-O-chitosan sulfate, is presented. Three different approaches are described for the immobilization of these core shell particles on cellulosic surfaces. The mass of the immobilized particles is quantified using a quartz crystal microbalance with dissipation (QCM-D). The antimicrobial activity of the surfaces towards E. coli MG 1655 [R1-16] is investigated by live/dead assays using fluorescence staining. All surfaces treated with the designed nanoparticles exhibit excellent antimicrobial activity towards E. coli MG 1655 [R1-16]. Anticoagulant properties of blood plasma on the nanoparticle treated surfaces have been determined using QCM-D. In comparison with the unmodified substrates, the total coagulation time as well as the thrombin formation time and fibrin clotting time of surfaces modified with nanoparticles are significantly increased.

AB - The rational design of silver nanoparticles encapsulated in an anticoagulant, hemocompatible polysaccharide, 6-O-chitosan sulfate, is presented. Three different approaches are described for the immobilization of these core shell particles on cellulosic surfaces. The mass of the immobilized particles is quantified using a quartz crystal microbalance with dissipation (QCM-D). The antimicrobial activity of the surfaces towards E. coli MG 1655 [R1-16] is investigated by live/dead assays using fluorescence staining. All surfaces treated with the designed nanoparticles exhibit excellent antimicrobial activity towards E. coli MG 1655 [R1-16]. Anticoagulant properties of blood plasma on the nanoparticle treated surfaces have been determined using QCM-D. In comparison with the unmodified substrates, the total coagulation time as well as the thrombin formation time and fibrin clotting time of surfaces modified with nanoparticles are significantly increased.

U2 - 10.1039/c3tb00272a

DO - 10.1039/c3tb00272a

M3 - Article

SN - 2050-7518

VL - 1

SP - 2022

EP - 2030

JO - Journal of Materials Chemistry B

JF - Journal of Materials Chemistry B

IS - 15

ER -